Activities per year
- 100 - 150 out of 289 results
Search results
-
A systematic review comparing physical activity mobile applications with and without pre-existing online social networks.
Jasmine Petersen (Participant), Ivanka Prichard (Participant) & Eva Kemps (Participant)
2019Activity: Other activity types › Other
-
From innovation to impact: how transformative legal education can address the challenges of our time
Tania Leiman (Participant)
1 Aug 2019 → …Activity: Other activity types › Other
-
Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. Held C, White HD, Stewart RAH, Davies R, Sampson S, Chiswell K, Silverstein A, Lopes RD, Heldestad U, Budaj A, Mahaffey KW, Wallentin L; STABILITY Investigators. Am Heart J. 2019 Feb;208:65-73. doi: 10.1016/j.ahj.2018.10.010. Epub 2018 Nov 7. PMID: 30572273 Clinical Trial.
Erin Morton (Other)
2019Activity: Other activity types › Other
-
Professor Christian Mueller discussing the RAPID TnT trial at the European Society of Cardiology Congress 2019
Erin Morton (Other)
2019Activity: Other activity types › Other
-
Media associated with ASA 2019 presentation
Sarah Appleton (Participant)
16 Oct 2019Activity: Other activity types › Other
-
Media associated with ASA 2019 presentation
Sarah Appleton (Participant)
21 Oct 2019Activity: Other activity types › Other
-
Contributor: The Food Medic Educational Blog
Emma Wallace (Participant)
Aug 2019 → …Activity: Other activity types › Other
-
Media activity associated with ASA 2019 presentation
Sarah Appleton (Participant)
18 Oct 2019Activity: Other activity types › Other
-
Delegate, Standards Australia SF-017 Committee for Occupational Diving (Scientific Diving Working Group Member)
Jonathan Benjamin (Other)
2018 → …Activity: Other activity types › Other
-
Mr Darcy as Vampire: a literary hero with bite - The Conversation
Eric Parisot (Participant)
30 Oct 2018Activity: Other activity types › Other
-
NHMRC Research Excellence Award 2018
Jamie Craig (Participant)
2018Activity: Other activity types › Other
-
Australian Research Council (ARC) Impact and Engagement, Humanities and Creative Arts panel (2018)
Penny Edmonds (Other)
2018Activity: Other activity types › Other
-
Palaeontology Field Expeditions to Antarctica (2016-2019)
John Long (Participant), Neil Shubin (Participant), Tim Senden (Participant), Ted Daeschler (Participant) & Adam Malouf (Participant)
3 Dec 2018 → 26 Jan 2019Activity: Other activity types › Other
-
ABC radio. Drive with Jules Schiller. Effects of the Time of the day on Myopia Development.
Ranjay Chakraborty (Participant)
1 May 2018Activity: Other activity types › Other
-
Primary Prevention. In Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Cancer Council Australia, 2018.
F. Macrae (Other), J. Clarke (Other), Jon Emery (Other), M. Jenkins (Other), T. Lockett (Other), J. McNeil (Other), Allan Spigelman (Other), N. Patcher (Other), Aung Ko Win (Other), R. Woods (Other), Graeme P. Young AM FTSE FAHMS AGAF (Other) & John R. Zalcberg (Other)
2018Activity: Other activity types › Other
-
Facing your Fears
Anthony Venning (Participant), Tasia Oswald (Participant), Paula Redpath (Participant), Sharon Lawn (Participant) & Andrea Morello (Participant)
2018Activity: Other activity types › Other
-
Judge, Romance Writers America RITA Award
Amy Matthews (Participant)
2018 → 2019Activity: Other activity types › Other
-
Judge, Romance Writers Australia RUBY Award
Amy Matthews (Participant)
2018 → 2019Activity: Other activity types › Other
-
Taking Command of Anxiety
Anthony Venning (Participant), Tasia Oswald (Participant), Paula Redpath (Participant), Sharon Lawn (Participant) & Andrea Morello (Participant)
2018Activity: Other activity types › Other
-
Public Speaker: SAHMRI public and school tours
Charlotte EJ Downes (Participant)
Feb 2018 → May 2022Activity: Other activity types › Other
-
Onto-existential Movements in Learning Design
Nicola Parkin (Other)
2018Activity: Other activity types › Other
-
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial. Ungar L, Clare RM, Rodriguez F, Kolls BJ, Armstrong PW, Aylward P, Held C, Moliterno DJ, Strony J, Van de Werf F, Wallentin L, White HD, Tricoci P, Harrington RA, Mahaffey KW, Melloni C. J Am Heart Assoc. 2018 Dec 18;7(24):e009609. doi: 10.1161/JAHA.118.009609. PMID: 30526198
Erin Morton (Other)
2018Activity: Other activity types › Other
-
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial. Tricoci P, Neely M, Whitley MJ, Edelstein LC, Simon LM, Shaw C, Fortina P, Moliterno DJ, Armstrong PW, Aylward P, White H, Van de Werf F, Jennings LK, Wallentin L, Held C, Harrington RA, Mahaffey KW, Bray PF. Blood Cells Mol Dis. 2018 Sep;72:37-43. doi: 10.1016/j.bcmd.2018.07.004. Epub 2018 Jul 21. PMID: 30055940. Clinical Trial.
Erin Morton (Other)
2018Activity: Other activity types › Other
-
ABC radio. Breakfast with Ali Clarke. "Influence of the Time of the Day on Myopia Development".
Ranjay Chakraborty (Participant)
1 May 2018Activity: Other activity types › Other
-
1395 FIVEaa radio with Rilka Warbanoff. "Myopia is increasing worldwide – is lack of sleep part of the issue?"
Ranjay Chakraborty (Participant)
1 Dec 2018Activity: Other activity types › Other
-
Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide. Gut, 2018 Apr;67(4):679-687. doi: 10.1136/gutjnl-2016-313311.
C.M. de Klerk (Other), S. Gupta (Other), E. Dekker (Other), M.L. Essink-Bot (Other), Expert Working Group ‘Coalition to reduce inequities in colorectal cancer screening’ of the World Endoscopy Organization (Other) & Graeme P. Young AM FTSE FAHMS AGAF (Other)
2018Activity: Other activity types › Other
-
How Pain affects my Thinking
Anthony Venning (Participant), Tasia Oswald (Participant), Paula Redpath (Participant), Sharon Lawn (Participant) & Andrea Morello (Participant)
2018Activity: Other activity types › Other
-
Pain Medication
Anthony Venning (Participant), Tasia Oswald (Participant), Paula Redpath (Participant), Sharon Lawn (Participant) & Andrea Morello (Participant)
2018Activity: Other activity types › Other
-
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Davis TME, Mulder H, Lokhnygina Y, Aschner P, Chuang LM, Raffo Grado CA, Standl E, Peterson ED, Holman RR; TECOS Study Group. Diabetes Obes Metab. 2018 Jun;20(6):1427-1434. doi: 10.1111/dom.13242. Epub 2018 Feb 28. PMID: 29405540 Clinical Trial.
Erin Morton (Other)
2018Activity: Other activity types › Other
-
How Anxiety affects Thinking
Anthony Venning (Participant), Tasia Oswald (Participant), Paula Redpath (Participant), Sharon Lawn (Participant) & Andrea Morello (Participant)
2018Activity: Other activity types › Other
-
Amphorae and maritime trade in Egypt in antiquity
Omaima Eldeeb (Participant)
20 Oct 2017 → 23 Oct 2017Activity: Other activity types › Other
-
Student Volunteer: AusBiotech conference 2017
Charlotte EJ Downes (Participant)
Oct 2017Activity: Other activity types › Other
-
Austen Powers - SA Weekend, The Advertiser
Eric Parisot (Participant)
1 Jul 2017Activity: Other activity types › Other
-
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study. Andrews J, Janssan A, Nguyen T, Pisaniello AD, Scherer DJ, Kastelein JJ, Merkely B, Nissen SE, Ray K, Schwartz GG, Worthley SG, Keyserling C, Dasseux JL, Butters J, Girardi J, Miller R, Nicholls SJ. Cardiovasc Diagn Ther. 2017 Feb;7(1):45-51. doi: 10.21037/cdt.2017.01.01. PMID: 28164012; PMCID: PMC5253449. H-index
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial. Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR; TECOS Study Group. Diabetes Care. 2017 Dec;40(12):1763-1770. doi: 10.2337/dc17-1091. Epub 2017 Oct 6. PMID: 28986504
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Guimarães PO, Granger CB, Stebbins A, Chiswell K, Held C, Hochman JS, Krug-Gourley S, Lonn E, Lopes RD, Stewart RAH, Vinereanu D, Wallentin L, White HD, Hagström E, Danchin N. J Am Heart Assoc. 2017 Sep 14;6(9):e006695. doi: 10.1161/JAHA.117.006695. PMID: 28912210. Clinical Trial.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
NHMRC Grant Management Solution Working Group
Roger Yazbek (Participant)
29 Nov 2017 → 17 May 2021Activity: Other activity types › Other
-
Fundraising Volunteer: Cancer Council Relay for Life
Charlotte EJ Downes (Participant)
Oct 2017Activity: Other activity types › Other
-
Austen-tatious - Tas Weekend, The Mercury
Eric Parisot (Participant)
8 Jul 2017Activity: Other activity types › Other
-
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial. Josse RG, Majumdar SR, Zheng Y, Adler A, Bethel MA, Buse JB, Green JB, Kaufman KD, Rodbard HW, Tankova T, Westerhout CM, Peterson ED, Holman RR, Armstrong PW; TECOS Study Group. Diabetes Obes Metab. 2017 Jan;19(1):78-86. doi: 10.1111/dom.12786. Epub 2016 Oct 6. PMID: 27607571 Clinical Trial.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. Engel SS, Suryawanshi S, Stevens SR, Josse RG, Cornel JH, Jakuboniene N, Riefflin A, Tankova T, Wainstein J, Peterson ED, Holman RR; TECOS Study Group. Diabetes Obes Metab. 2017 Nov;19(11):1587-1593. doi: 10.1111/dom.12983. Epub 2017 Jul 7. PMID: 28432745 Clinical Trial.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. Stewart RAH, Held C, Hadziosmanovic N, Armstrong PW, Cannon CP, Granger CB, Hagström E, Hochman JS, Koenig W, Lonn E, Nicolau JC, Steg PG, Vedin O, Wallentin L, White HD; STABILITY Investigators. J Am Coll Cardiol. 2017 Oct 3;70(14):1689-1700. doi: 10.1016/j.jacc.2017.08.017. PMID: 28958324 Clinical Trial.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Post Traumatic Stress Disorder: Processing the Past, Redefining the Future
Anthony Venning (Participant), Paula Redpath (Participant) & Tassia K. Oswald (Participant)
30 Jan 2017Activity: Other activity types › Other
-
Effects of probiotic+prebiotic supplementation on cognition, mental well-being and mood.
Reneshree Govender (Participant), Eva Kemps (Participant), Katie Tooley (Participant), Diane Pomeroy (Participant) & B. Probert (Participant)
2017Activity: Other activity types › Other
-
Anxiety group program
Anthony Venning (Participant), Paula Redpath (Participant), Tasia Oswald (Participant), Andrea Morello (Participant) & Sharon Lawn (Participant)
2017Activity: Other activity types › Other
-
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. Held C, White HD, Stewart RAH, Budaj A, Cannon CP, Hochman JS, Koenig W, Siegbahn A, Steg PG, Soffer J, Weaver WD, Östlund O, Wallentin L; STABILITY Investigators. J Am Heart Assoc. 2017 Oct 24;6(10):e005077. doi: 10.1161/JAHA.116.005077. PMID: 29066452. Clinical Trial.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib. Yeo A, Li L, Warren L, Aponte J, Fraser D, King K, Johansson K, Barnes A, MacPhee C, Davies R, Chissoe S, Tarka E, O'Donoghue ML, White HD, Wallentin L, Waterworth D. PLoS One. 2017 Jul 28;12(7):e0182115. doi: 10.1371/journal.pone.0182115. eCollection 2017. PMID: 28753643.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease. Gryka RJ, Buckley LF, Anderson SM. Drugs R D. 2017 Mar;17(1):65-72. doi: 10.1007/s40268-016-0158-4. PMID: 28063023. Review.
Erin Morton (Other)
2017Activity: Other activity types › Other
-
Re-Thinking Chronic Pain
Paula Redpath (Participant), Anthony Venning (Participant), Tasia Oswald (Participant) & Cindy Wall (Participant)
30 Jan 2017Activity: Other activity types › Other
-
Pain Group program
Paula Redpath (Participant), Anthony Venning (Participant), Tasia Oswald (Participant), Andrea Morello (Participant) & Sharon Lawn (Participant)
2017Activity: Other activity types › Other